Biology subjects

McPherson, R.

Publications and source records attributed to McPherson, R..

9 recordsLinked to original sources

bioRxiv2026

Exon Resolved Dissection of Shared, Unique, and Antagonistic Functions of ZFAS1 Isoforms

The long noncoding RNA ZFAS1 plays a role in cell proliferation and has been linked to cancer development and prognosis. However, the ZFAS1 locus is predicted to encode over 40 ZFAS1 splice variants, which remain largely uncharacterized. To shed light on the role of ZFAS1 in hepatocyte models, we examined the transcriptome-wide effects of separately targeting three exons present in representative ZFAS1 variants with gapmer antisense oligonucleotides. Evidence of cross-exon compensatory regulation was obtained by qRT-PCR. Although targeting resulted in a subset of concerted transcript perturbations-indicating specificity and shared functionalities-the overall effects were predominantly non-redundant. Overrepresentation analyses revealed that proximal exon and distal exon targeting affected cell cycle and transcription regulation, respectively. Strikingly, interrogation of the entire transcriptome with gene set enrichment analysis identified a shared subset of pathways related to cell-cycle control and translation, which were affected antagonistically in an exon-dependent manner. Whereas targeting the proximal exon was predicted to broadly compromise cell-cycle and translational functions, targeting distal exons produced contrasting effects on these processes. Together, these findings demonstrate that the arrangement of ZFAS1 exons can markedly modulate its function.

cell biology↗

bioRxiv2025

Deciphering the role of the lncRNA TRIBAL in hepatocyte models

We recently reported that the long non-coding RNA TRIBAL/TRIB1AL was required to sustain key hepatocyte functions. Here, we identify HepaRG cells as a model for studying TRIBAL and provide additional validation and functional insights. In contrast to HepG2 and HuH-7 cells, differentiated HepaRG cells showed similarities to primary hepatocytes in response to TRIBAL suppression. TRIBAL suppression was associated with reduced HNF4A and MLXIPL abundance in hepatocytes and HepaRG cells. TRIBAL targeting using a panel of targeting ASOs confirmed specificity. Comparing TRIBAL-suppressed hepatocyte and HepaRG transcriptomics identified extensive functional overlap. Biological ontologies associated with key hepatic metabolic functions were predicted to be inhibited in both models. Comparative analyses with TRIB1-suppressed HepaRG cells, a major metabolic regulator vicinal to TRIBAL, also revealed extensive functional congruence with TRIBAL. Interestingly, TRIBAL transduction failed to restore function in TRIBAL-suppressed cells, which may be linked to structural differences, as supported by contrasting RNAseR sensitivities between the endogenous and transduced forms. In summary, these findings support the use of HepaRG cells as an experimental model to study TRIBAL and underscore its importance in regulating key hepatocyte genes essential for metabolic function.

cell biology↗

bioRxiv2024

Constitutive Photomorphogenesis Protein 1 homolog (COP1) sustains nuclear factor-4 alpha function in human hepatocyte models

Constitutive Photomorphogenesis Protein 1 homolog (COP1) is a conserved E3 ligase with key roles in several biological systems. Prior work in hepatocyte derived tumors categorized COP1 as an oncogene but its role in untransformed hepatocytes remains largely unexplored. Here we have investigated the role of COP1 in primary human hepatocytes as well as in two transformed hepatocyte models, HepG2 and HuH-7 cells. Contrary to a previous report, COP1 suppression via siRNA had no noticeable impact on HepG2 and HuH-7 proliferation and was associated with contrasting rather than congruent transcriptome changes. Clustering analyses identified patterns indicative of perturbed metabolism in primary hepatocytes and HepG2 cells whereas patterns pointed to cell proliferation impacts in HuH-7 cells. In HepG2 and primary hepatocytes, COP1 suppression reduced the expression important hepatic regulators and markers, which could be restored by the introduction of a siRNA resistant COP1 transgene. COP1 downregulation reduced hepatic nuclear factor-4 alpha (HNF4A) abundance and function, as assessed by lower abundance of key HNF4A targets and reduced APOB secretion. HNF4A restoration partially rescued COP1 silencing in HepG2 cells. This study identifies COP1 as a key regulator of hepatocyte function, in part via HNF4A. COP1 was required to maintain HNF4A abundance and function in primary hepatocytes and in HepG2 cells, but not in HuH-7 cells. Lastly, by demonstrating contrasting roles of COP1 in HuH-7 and HepG2 cells, our findings also challenge previous work linking COP1 to hepatic tumorigenesis.

cancer biology↗

bioRxiv2022

"Wissenschaft fürs Wohnzimmer" - two years of interactive, scientific livestreams weekly on YouTube

Science communication is becoming increasingly important to connect academia and society, and to counteract fake news among climate change deniers. Online video platforms, such as YouTube, offer great potential for low-threshold communication of scientific knowledge to the general public. In April 2020 a diverse group of researchers from the Alfred Wegener Institute Helmholtz Centre for Polar and Marine Research launched the YouTube channel "Wissenschaft furs Wohnzimmer" (translated to "Sitting Room Science") to stream scientific talks about climate change and biodiversity every Thursday evening. Here we report on the numbers and diversity of content, viewers, and presenters from 2 years and 100 episodes of weekly livestreams. Presented topics encompass all areas of polar research, social issues related to climate change, and new technologies to deal with the changing world and climate ahead. We show that constant engagement by a group of co-hosts, and presenters from all topics, career stages, and genders enable a continuous growth of views and subscriptions, i.e. impact. After 783 days the channel gained 30,251 views and 828 subscribers and hosted well-known scientists while enabling especially early career researchers to improve their outreach and media skills. We show that interactive and science-related videos, both live and on-demand, within a pleasant atmosphere, can be produced voluntarily while maintaining high quality. We further discuss challenges and possible improvements for the future. Our experiences may help other researchers to conduct meaningful scientific outreach and to push borders of existing formats with the overall aim of developing a better understanding of climate change and our planet.

scientific communication and education↗

bioRxiv2022

Regulation of TRIB1 abundance in hepatoma models

Tribbles related homolog 1 (TRIB1) contributes to lipid and glucose homeostasis by facilitating the degradation of cognate cargos by the proteasome. We previously reported that TRIB1 was unstable in non-hepatic cellular models. Moreover, inclusion of proteasome inhibitors failed to prevent TRIB1 loss, consistent with the involvement of proteasome independent degradative processes. In view of the key role of TRIB1 in liver function, we continue our exploration of TRIB1 regulation pathways in two commonly used human hepatocyte models, HuH-7 and HepG2 cells. Proteasome inhibitors potently upregulated both endogenous and recombinant TRIB1 mRNA and protein levels. Increased transcript abundance was independent of MAPK activation while ER stress was a relatively mild inducer. Despite increasing TRIB1 protein abundance and stabilizing bulk ubiquitination, proteasome inhibition failed to stabilize TRIB1, pointing to the predominance of proteasome independent protein degradation processes controlling TRIB1 protein abundance in hepatomas. Proteasome inhibition via downregulation of its PSMB3 regulatory subunit, in contrast to its chemical inhibition, had minimal impact on TRIB1 levels. Moreover, immunoprecipitation experiments showed no evidence of TRIB1 ubiquitination. Cytoplasmic retained TRIB1 was unstable, indicating that TRIB1 lability is regulated prior to its nuclear import. Substitution of the TRIB1 PEST-like region with a GST helical region or N-terminal deletions failed to fully stabilize TRIB1. Finally, inclusion of protease or autophagy inhibitors in vivo did not rescue TRIB1 stability. This work excludes proteasome-mediated degradation as a significant contributor to TRIB1 instability and identifies transcriptional regulation as a prominent mechanism regulating TRIB1 abundance in liver models in response to proteasome inhibition.

cell biology↗

bioRxiv2022

The antimicrobial peptide cathelicidin is critical for the development of Th17 responses in severe inflammatory disease

Multiple Sclerosis (MS) is a highly prevalent demyelinating autoimmune condition; the mechanisms regulating its severity and progression are unclear. The IL-17-producing Th17 subset of T cells has been widely implicated in MS and in the mouse model, experimental autoimmune encephalomyelitis (EAE). However, the differentiation and regulation of Th17 cells during EAE remain incompletely understood. Although evidence is mounting that the antimicrobial peptide cathelicidin profoundly affects early T cell differentiation, no studies have looked at its role in longer term T cell responses. Now, we report that cathelicidin drives severe EAE disease. It is released from neutrophils, microglia and endothelial cells throughout disease; its interaction with T cells potentiates Th17 differentiation in lymph nodes and Th17 to exTh17 plasticity and IFN-{gamma} production in the spinal cord. As a consequence, mice lacking cathelicidin are protected from severe EAE. In addition, we show that cathelicidin is produced by the same cell types in the active brain lesions in human MS disease. We propose that cathelicidin exposure results in highly activated, cytokine-producing T cells which drive autoimmunity; this is a mechanism through which neutrophils amplify inflammation in the central nervous system.

immunology↗

bioRxiv2021

A common polymorphism that protects from cardiovascular disease increases fibronectin processing and secretion

BackgroundFibronectin (FN1) is an essential regulator of homodynamic processes and tissue remodeling which has been proposed to contribute to atherosclerosis. Moreover, recent large scale genome wide association studies have linked common genetic variants within the FN1 gene to coronary artery disease (CAD) risk. MethodsPublic databases were analyzed by two-Sample Mendelian Randomization. Expression constructs encoding short FN1 reporter constructs and full-length plasma FN1, differing in the polymorphism, were designed and introduced in various cell models. Secreted and cellular levels were then analyzed and quantified by SDS-PAGE and fluorescence approaches. Mass spectrometry and glycosylation analyses were performed to probe possible post-transcriptional differences. ResultsHigher FN1 protein levels in plasma associates with a reduced risk of cardiovascular disease. Moreover, common CAD risk SNPs in the FN1 locus associate with circulating levels of FN1. This region is shown to encompass a L15Q polymorphism within the FN1 signal peptide. The presence of the minor allele that predisposes to CAD, corresponding to the Q15 variant, alters glycosylation and reduces FN1 secretion in a direction consistent with the bioinformatic analyses. ConclusionIn addition to providing novel functional evidence implicating FN1 as a protective force in cardiovascular disease, these findings demonstrate that a common variant within a secretion signal peptide regulates protein function.

biochemistry↗

bioRxiv2019

Heterozygous ATP-binding Cassette Transporter G5 Gene Deficiency and Risk of Coronary Artery Disease

BackgroundFamilial sitosterolemia is a rare, recessive Mendelian disorder characterized by hyperabsorption and decreased biliary excretion of dietary sterols. Affected individuals typically have complete genetic deficiency - homozygous loss-of-function (LoF) variants -- in the ATP-binding cassette transporter G5 (ABCG5) or G8 (ABCG8) genes, and have substantially elevated plasma sitosterol and low-density lipoprotein cholesterol (LDL-C) levels. The impact of partial genetic deficiency of ABCG5 or ABCG8, as occurs in heterozygous carriers of LoF variants, on LDL-C and risk of coronary artery disease (CAD) has remained uncertain.\n\nMethodsWe first recruited nine sitosterolemia families, identified causative LoF variants in ABCG5 or ABCG8, and evaluated the associations of these ABCG5 or ABCG8 LoF variants with plasma phytosterols and lipid levels. We next assessed for LoF variants in ABCG5 or ABCG8 in CAD cases (n=29,361) versus controls (n=357,326). We tested the association of rare LoF variants in ABCG5 or ABCG8 with blood lipids and risk for CAD. Rare LoF variants were defined as protein-truncating variants with minor allele frequency less than 0.1% in ABCG5 or ABCG8.\n\nResultsIn sitosterolemia families, seven pedigrees harbored causative LoF variants in ABCG5 and two pedigrees in ABCG8. Homozygous LoF variants in either ABCG5 or ABCG8 led to marked elevations in sitosterol and LDL-C. Of those sitosterolemia families, heterozygous carriers of ABCG5 LoF variants exhibited increased sitosterol and LDL-C levels compared to non-carriers. Within the large-scale CAD case-control cohorts, prevalence of rare LoF variants in ABCG5 and in ABCG8 were approximately 0.1% each. ABCG5 heterozygous LoF variant carriers had significantly elevated LDL-C levels (24.7 mg/dL; 95% confidence interval [CI] 14 to 35; P=1.1x10-6), and were at two-fold increased risk of CAD (odds ratio 2.06, 95% CI 1.27 to 3.35; P=0.004). By contrast, ABCG8 heterozygous LoF carrier status was not associated with increased LDL-C or risk of CAD.\n\nConclusionsAlthough familial sitosterolemia is traditionally considered as a recessive disorder, we observed that heterozygous carriers of a LoF variant in ABCG5 had significantly increased sitosterol and LDL-C levels and a two-fold increase in risk of CAD.

genetics↗

bioRxiv2019

A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease

Analyzing 5770 all-cause cirrhosis cases and 572,850 controls from seven cohorts, we identify a missense variant in the Mitochondrial Amidoxime Reducing Component 1 gene (MARC1 p.A165T) that associates with protection from all-cause cirrhosis (OR 0.88, p=2.1*10-8). This same variant also associates with lower levels of hepatic fat on computed tomographic imaging and lower odds of physician-diagnosed fatty liver as well as lower blood levels of alanine transaminase (-0.012 SD, 1.4*10-8), alkaline phosphatase (-0.019 SD, 6.6*10-9), total cholesterol (-0.037 SD, p=1*10-18) and LDL cholesterol (-0.035 SD, p=7.3*10-16). Carriers of rare protein-truncating variants in MARC1 had lower liver enzyme levels, cholesterol levels, and reduced odds of liver disease (OR 0.19, p= 0.04) suggesting that deficiency of the MARC1 enzyme protects against cirrhosis.

genomics↗